NCT03217617: SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection
- State
- Not started
- Phase
- Phase 1 and Phase 2
- People
- 10 planned
- Started
- 30 Jun 2027
- Primary completion
- 31 Dec 2028
- Arms
- Single arm
- Results
- None posted
- 14 Jul 2017: Trial registered